News

Plug-and-play simplicity meets the demands of modern digital pathology workflows Newcastle, United Kingdom – July 22, 2025 – Leica Biosystems, a global leader in anatomic and digital pathology solutions, today unveiled ChromoPlex III Triple Detection RUO, a chromogenic multiplex…

Danaher has entered a partnership with AstraZeneca to scale precision medicine, including developing the next generation of AI-powered diagnostics This partnership aims to create a framework for rapid diagnostics research, development and commercialization Danaher, through its Centers for Enabling…

Melbourne, Australia – April 2, 2025 – Leica Biosystems, a global leader in anatomic pathology solutions, and Advanced Cell Diagnostics (ACD), a Bio-Techne brand and a global leader in spatial biology, today announced an expansion of their longstanding partnership to offer innovative spatial…

Suzhou, China - March 26, 2025 - Leica Biosystems, a global leader in anatomic pathology, today announced a strategic partnership with CellCarta, a globally recognized Contract Research Organization laboratory serving the biopharmaceutical industry. This partnership combines Leica Biosystems'…

Leica Biosystems is pleased to announce the launch of two new primary antibodies, PD-L1 and HER2, developed to support cancer research and therapy development. These antibodies, widely used in studying breast, lung, and other cancers, underscore our commitment to empowering pharmaceutical partners…